Sissetulev dokumentAvalik
Kiri
Terviseamet · 13. november 2024
- Viit
- 11.1-2/24/11559-1
- Registreeritud
- 13. november 2024
- Dokumendi liik
- Sissetulev dokument
- Adressaat
- B. Braun Medical OÜ
- Saabumis/saatmisviis
- e-post
- Funktsioon
- 11.1 SULETUD 2025 Turustamise järgne järelevalve (post-marketing surveillance)
- Sari
- 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks
- Toimik
- 11.1-2/2023
- Vastutaja
- Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)
Sisu (failidest)
Saatja: Toomas Puskarjov <[email protected]>
Saaja: Meditsiiniseadmed (Medical Devices)
Teema: B.Braun tootja küsimus: Registered/Notified Medical Devices - Changes’ impact
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Tere
Edastan tootja B.Braun Melsungen küsimuse:
I am contacting you regarding the topic of global changes impacting the approved registration certificate/registered documentation / notification for medical devices (active, non-active), as I would require your support in better understanding which types of global changes would have an effect in your country.
The reason for this query is to become more efficient in the future, when evaluating the global impact of the changes, and to get in contact and inform you only when this would be applicable for you.
Please, answer on the following:
1. Do you have to inform the Authority about any changes? Yes/No
2. In case, the answer to the question 1 is ‘Yes’, which changes do you have to submit to the Authority?
3. Is there a law/guideline regulating the changes which have to be submitted to the Authority? Yes/No
if ‘Yes’, please, send the full version of the regulation in your language and just translate necessary part regarding changes’ impact into English.
Seni tuli teavitada seadmel tehtavatest olulistest muudatustest (kuigi ka need ei olnud väga täpselt määratletud).
Ette tänades,
Toomas Puskarjov
Regulatory Affairs Manager
Compliance Officer
+372 5139366
[email protected]<mailto:[email protected]>
B. Braun Medical OÜ
Pilvetee 8
12618 Tallinn
Estonia
________________________________
The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of the company of the sender of this e-mail. Unauthorized use, disclosure, or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail and destroy this communication and all copies thereof, including all attachments.